Gilead Sciences Debt to Equity Ratio 2006-2018 | GILD

Current and historical debt to equity ratio values for Gilead Sciences (GILD) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Gilead Sciences debt/equity for the three months ending June 30, 2018 was 1.23.
Gilead Sciences Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-06-30 $26.71B $21.73B 1.23
2018-03-31 $27.23B $20.65B 1.32
2017-12-31 $31.35B $20.50B 1.53
2017-09-30 $27.77B $25.25B 1.10
2017-06-30 $26.74B $23.09B 1.16
2017-03-31 $26.32B $20.92B 1.26
2016-12-31 $26.64B $19.36B 1.38
2016-09-30 $26.56B $17.36B 1.53
2016-06-30 $21.89B $16.12B 1.36
2016-03-31 $21.45B $14.02B 1.53
2015-12-31 $21.47B $19.11B 1.12
2015-09-30 $22.28B $17.94B 1.24
2015-06-30 $12.69B $16.63B 0.76
2015-03-31 $12.55B $17.59B 0.71
2014-12-31 $12.52B $15.82B 0.79
2014-09-30 $8.44B $13.86B 0.61
2014-06-30 $8.14B $16.43B 0.50
2014-03-31 $8.15B $13.70B 0.60
2013-12-31 $4.00B $11.75B 0.34
2013-09-30 $6.12B $11.19B 0.55
2013-06-30 $6.07B $11.34B 0.54
2013-03-31 $7.27B $10.39B 0.70
2012-12-31 $7.31B $9.54B 0.77
2012-09-30 $7.26B $8.75B 0.83
2012-06-30 $7.28B $8.08B 0.90
2012-03-31 $8.23B $7.36B 1.12
2011-12-31 $7.75B $6.87B 1.13
2011-09-30 $4.03B $6.23B 0.65
2011-06-30 $4.03B $6.21B 0.65
2011-03-31 $3.90B $6.18B 0.63
2010-12-31 $2.87B $6.12B 0.47
2010-09-30 $2.87B $5.88B 0.49
2010-06-30 $0.59B $6.70B 0.09
2010-03-31 $1.20B $7.50B 0.16
2009-12-31 $1.19B $6.51B 0.18
2009-09-30 $1.18B $5.75B 0.21
2009-06-30 $1.18B $5.31B 0.22
2009-03-31 $1.13B $5.02B 0.23
2008-12-31 $1.12B $4.47B 0.25
2008-09-30 $1.32B $4.17B 0.32
2008-06-30 $0.03B $3.77B 0.01
2008-03-31 $1.31B $3.33B 0.39
2007-12-31 $1.31B $3.46B 0.38
2007-09-30 $1.42B $2.98B 0.48
2007-06-30 $1.41B $2.49B 0.57
2007-03-31 $1.40B $2.38B 0.59
2006-12-31 $1.39B $1.82B 0.77
2006-09-30 $1.38B $3.30B 0.42
2006-06-30 $1.44B $3.20B 0.45
2006-03-31 $0.18B $3.39B 0.05
2005-12-31 $0.24B $3.03B 0.08
2005-09-30 $0.00B $2.62B 0.00
2005-06-30 $0.00B $2.39B 0.00
2005-03-31 $0.00B $2.06B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $96.150B $26.107B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.215B 15.06
Biogen (BIIB) United States $66.506B 14.10
Celgene (CELG) United States $58.344B 11.65
Illumina (ILMN) United States $47.253B 59.20
Vertex Pharmaceuticals (VRTX) United States $45.720B 104.01
Regeneron Pharmaceuticals (REGN) United States $42.706B 24.01
Alexion Pharmaceuticals (ALXN) United States $28.205B 21.20
BioMarin Pharmaceutical (BMRN) United States $18.437B 0.00
Incyte (INCY) United States $13.698B 460.29
Seattle Genetics (SGEN) United States $11.706B 0.00
Sarepta Therapeutics (SRPT) United States $9.222B 0.00
QIAGEN (QGEN) Netherlands $8.091B 26.45
Alnylam Pharmaceuticals (ALNY) United States $7.911B 0.00
Exact Sciences (EXAS) United States $7.791B 0.00
Bio-Techne Corp (TECH) United States $6.919B 46.28
BeiGene (BGNE) Cayman Islands $6.673B 0.00
Bluebird Bio (BLUE) United States $6.615B 0.00
Alkermes (ALKS) Ireland $6.337B 0.00
Amarin (AMRN) Ireland $5.879B 0.00
Galapagos (GLPG) Belgium $5.385B 0.00
Exelixis (EXEL) United States $4.924B 16.04
Immunomedics (IMMU) United States $4.241B 0.00
Ligand Pharmaceuticals (LGND) United States $4.159B 36.83
GUARDANT HEALTH (GH) United States $3.351B 0.00
Myriad Genetics (MYGN) United States $3.332B 35.39
Array BioPharma (ARRY) United States $3.292B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.219B 0.00
Horizon Pharma Public (HZNP) Ireland $3.181B 18.01
Emergent Biosolutions (EBS) United States $3.086B 24.58
MorphoSys AG Unsponsored ADR (MOR) Germany $3.078B 0.00
Blueprint Medicines (BPMC) United States $3.059B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.940B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.841B 0.00
Ascendis Pharma (ASND) Denmark $2.772B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.695B 0.00
Halozyme Therapeutics (HALO) United States $2.538B 33.83
Repligen (RGEN) United States $2.475B 83.10
Genomic Health (GHDX) United States $2.437B 135.92
China Biologic Products (CBPO) China $2.394B 16.46
Acceleron Pharma (XLRN) United States $2.378B 0.00
Amicus Therapeutics (FOLD) United States $2.324B 0.00
MyoKardia (MYOK) United States $2.232B 0.00
REGENXBIO (RGNX) United States $2.016B 31.67
Medicines (MDCO) United States $2.010B 0.00
Arena Pharmaceuticals (ARNA) United States $2.000B 0.00
Global Blood Therapeutics (GBT) United States $1.986B 0.00
Akcea Therapeutics (AKCA) United States $1.955B 0.00
AnaptysBio (ANAB) United States $1.953B 0.00
Cambrex (CBM) United States $1.888B 15.14
Spark Therapeutics (ONCE) United States $1.874B 0.00
Reata Pharmaceuticals (RETA) United States $1.818B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.795B 0.00
Allakos (ALLK) United States $1.788B 0.00
CRISPR THERAPTC (CRSP) Switzerland $1.756B 0.00
Puma Biotechnology (PBYI) United States $1.657B 0.00
Atara Biotherapeutics (ATRA) United States $1.622B 0.00
Aimmune Therapeutics (AIMT) United States $1.620B 0.00
Clovis Oncology (CLVS) United States $1.577B 0.00
Innoviva (INVA) United States $1.570B 10.08
G1 THERAPEUTICS (GTHX) United States $1.567B 0.00
Denali Therapeutics (DNLI) United States $1.561B 0.00
Sangamo Therapeutics (SGMO) United States $1.443B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.435B 0.00
WAVE Life Sciences (WVE) Singapore $1.432B 0.00
Myovant Sciences (MYOV) United Kingdom $1.389B 0.00
Rubius Therapeutics (RUBY) United States $1.357B 0.00
Mirati Therapeutics (MRTX) United States $1.355B 0.00
Editas Medicine (EDIT) United States $1.352B 0.00
Insmed (INSM) United States $1.312B 0.00
IMMURON LTD (IMRN) Australia $1.287B 0.00
Solid Biosciences (SLDB) United States $1.258B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.202B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.187B 2267.00
Momenta Pharmaceuticals (MNTA) United States $1.154B 0.00
NeoGenomics (NEO) United States $1.140B 199.43
Cellectis (CLLS) France $1.122B 0.00
DBV Technologies (DBVT) France $1.087B 0.00
UniQure (QURE) Netherlands $1.047B 0.00
Lion Biotechnologies (IOVA) United States $1.044B 0.00
Audentes Therapeutics (BOLD) United States $1.035B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.033B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.027B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.026B 0.00
Retrophin (RTRX) United States $1.025B 0.00
Intra-Cellular Therapies (ITCI) United States $1.025B 0.00
Intellia Therapeutics (NTLA) United States $1.006B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.961B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $0.957B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.916B 0.00
Athenex (ATNX) United States $0.903B 0.00
Acorda Therapeutics (ACOR) United States $0.901B 18.78
Revance Therapeutics (RVNC) United States $0.896B 0.00
Aptinyx (APTX) United States $0.883B 0.00
Viking Therapeutics (VKTX) United States $0.876B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.875B 0.00
Coherus BioSciences (CHRS) United States $0.862B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.808B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.790B 0.00
Cara Therapeutics (CARA) United States $0.784B 0.00
Apellis Pharmaceuticals (APLS) United States $0.779B 0.00
InflaRx (IFRX) Germany $0.775B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.767B 0.00
Heska (HSKA) United States $0.750B 64.57
Novavax (NVAX) United States $0.746B 0.00
CytomX Therapeutics (CTMX) United States $0.740B 0.00
Fate Therapeutics (FATE) United States $0.736B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.727B 0.00
Dynavax Technologies (DVAX) United States $0.712B 0.00
Epizyme (EPZM) United States $0.696B 0.00
AVROBIO (AVRO) United States $0.687B 0.00
Mesoblast (MESO) Australia $0.664B 0.00
ANI Pharmaceuticals (ANIP) United States $0.662B 13.10
AC Immune SA (ACIU) Switzerland $0.634B 0.00
ObsEva SA (OBSV) Switzerland $0.613B 0.00
Anika Therapeutics (ANIK) United States $0.595B 25.04
Kura Oncology (KURA) United States $0.591B 0.00
UROGEN PHARMA (URGN) Israel $0.581B 0.00
MiMedx (MDXG) United States $0.575B 24.67
Arcus Biosciences (RCUS) United States $0.551B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.547B 0.00
RA PHARMCTL INC (RARX) United States $0.531B 0.00
Aduro Biotech (ADRO) United States $0.514B 0.00
Principia Biopharma (PRNB) United States $0.507B 0.00
Vericel (VCEL) United States $0.507B 0.00
Five Prime Therapeutics (FPRX) United States $0.507B 0.00
Inovio Pharmaceuticals (INO) United States $0.505B 0.00
ARVINAS INC (ARVN) United States $0.497B 0.00
UNITY Biotechnology (UBX) $0.496B 0.00
Prothena (PRTA) Ireland $0.489B 0.00
Scholar Rock Holding (SRRK) United States $0.487B 0.00
Kezar Life Sciences (KZR) United States $0.480B 0.00
Stemline Therapeutics (STML) United States $0.479B 0.00
Senesco Technologies (ELOX) United States $0.471B 0.00
Abeona Therapeutics (ABEO) United States $0.466B 0.00
MediciNova (MNOV) United States $0.451B 0.00
GRITSTONE ONCLG (GRTS) United States $0.447B 0.00
BeyondSpring (BYSI) United States $0.445B 0.00
Kindred Biosciences (KIN) United States $0.442B 0.00
Verastem (VSTM) United States $0.431B 0.00
Zealand Pharma (ZEAL) Denmark $0.428B 0.00
Cytokineticsorporated (CYTK) United States $0.425B 0.00
Liquidia Technologies (LQDA) United States $0.424B 0.00
Zymeworks (ZYME) Canada $0.423B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.421B 0.00
Sorrento Therapeutics (SRNE) United States $0.416B 71.20
Sinovac Biotech (SVA) China $0.411B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.388B 0.00
Merus (MRUS) Netherlands $0.387B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.383B 0.00
Replimune (REPL) United States $0.382B 0.00
Proteostasis Therapeutics (PTI) United States $0.380B 0.00
MeiraGTx Holdings (MGTX) United States $0.375B 0.00
PDL BioPharma (PDLI) United States $0.372B 5.22
UROVANT SCIENCS (UROV) United States $0.366B 0.00
KODIAK SCIENCES (KOD) United States $0.356B 0.00
Osiris Therapeutics (OSIR) United States $0.354B 0.00
Eidos Therapeutics (EIDX) United States $0.348B 0.00
Albireo Pharma (ALBO) United States $0.339B 0.00
ResTORbio (TORC) United States $0.339B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.339B 0.00
Selecta Biosciences (SELB) United States $0.339B 0.00
SUTRO BIOPHARMA (STRO) United States $0.332B 0.00
Magenta Therapeutics (MGTA) United States $0.325B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.321B 0.00
Evelo Biosciences (EVLO) United States $0.317B 0.00
Kala Pharmaceuticals (KALA) United States $0.317B 0.00
Geron (GERN) United States $0.314B 0.00
MannKind (MNKD) United States $0.314B 0.00
Kadmon Holdings (KDMN) United States $0.310B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.307B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.301B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.298B 0.00
Adverum Biotechnologies (ADVM) United States $0.295B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.294B 0.00
Unum Therapeutics (UMRX) United States $0.293B 0.00
Athersys (ATHX) United States $0.291B 0.00
Celcuity (CELC) United States $0.291B 0.00
Cellular Biomedicine (CBMG) United States $0.288B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.286B 0.00
Axovant Sciences (AXON) United Kingdom $0.286B 0.00
Seres Therapeutics (MCRB) United States $0.270B 0.00
ADMA Biologics Inc (ADMA) United States $0.259B 0.00
Celyad SA (CYAD) Belgium $0.257B 0.00
BioTime (BTX) United States $0.256B 0.00
TOCAGEN INC (TOCA) United States $0.253B 0.00
Arbutus Biopharma (ABUS) Canada $0.246B 0.00
Syros Pharmaceuticals (SYRS) United States $0.245B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.238B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.237B 0.00
Synlogic (SYBX) United States $0.235B 0.00
Kamada (KMDA) Israel $0.232B 17.97
Idera Pharmaceuticals (IDRA) United States $0.231B 0.00
Strongbridge Biopharma (SBBP) United States $0.230B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.229B 0.00
Krystal Biotech (KRYS) United States $0.227B 0.00
Agenus (AGEN) United States $0.227B 0.00
NantKwest (NK) United States $0.219B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.219B 0.00
BioDelivery Sciences (BDSI) United States $0.219B 0.00
Allena Pharmaceuticals (ALNA) United States $0.218B 0.00
Protagonist Therapeutics (PTGX) United States $0.212B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.207B 0.00
ChromaDex (CDXC) United States $0.203B 0.00
Compugen (CGEN) Israel $0.195B 0.00
Mersana Therapeutics (MRSN) United States $0.192B 0.00
Palatin Technologies (PTN) United States $0.187B 7.71
Spring Bank Pharmaceuticals (SBPH) United States $0.184B 0.00
Constellation Pharmaceuticals (CNST) United States $0.183B 0.00
Cerecor (CERC) United States $0.182B 18.63
Eiger BioPharmaceuticals (EIGR) United States $0.171B 0.00
Clearside Biomedical (CLSD) United States $0.171B 0.00
Intec Pharma (NTEC) Israel $0.169B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.169B 0.00
Cohbar (CWBR) United States $0.165B 0.00
Enzo Biochem (ENZ) United States $0.162B 0.00
PSivida (EYPT) United States $0.159B 0.00
CorMedix Inc (CRMD) United States $0.158B 0.00
Spero Therapeutics (SPRO) United States $0.155B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.154B 0.00
Signal Genetics (MGEN) United States $0.150B 0.00
OVID THERAPEUTC (OVID) United States $0.145B 0.00
Pfenex (PFNX) United States $0.142B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.141B 0.00
Cue Biopharma (CUE) United States $0.141B 0.00
Menlo Therapeutics (MNLO) United States $0.138B 0.00
VBI Vaccines (VBIV) United States $0.136B 0.00
Pluristem Therapeutics (PSTI) Israel $0.134B 0.00
Monster Digital (INNT) United States $0.134B 0.00
Mustang Bio (MBIO) United States $0.132B 0.00
XBiotech (XBIT) United States $0.130B 0.00
Eleven Biotherapeutics (SESN) United States $0.127B 0.00
Motif Bio Plc (MTFB) United States $0.125B 0.00
Organovo Holdings (ONVO) United States $0.123B 0.00
Catalyst Biosciences (CBIO) United States $0.118B 0.00
Applied Genetic Technologies (AGTC) United States $0.117B 0.00
ITUS (ANIX) United States $0.117B 0.00
VTv Therapeutics (VTVT) United States $0.116B 0.00
XOMA (XOMA) United States $0.115B 12.13
Provention Bio (PRVB) United States $0.115B 0.00
Anavex Life Sciences (AVXL) United States $0.112B 0.00
Cidara Therapeutics (CDTX) United States $0.110B 0.00
Axsome Therapeutics (AXSM) United States $0.108B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.103B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.102B 0.00
Cel-Sci (CVM) United States $0.102B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.100B 0.00
BioXcel Therapeutics (BTAI) United States $0.099B 0.00
Leap Therapeutics (LPTX) United States $0.099B 0.00
Neothetics (EVFM) United States $0.098B 0.00
Aptevo Therapeutics (APVO) United States $0.097B 0.00
Orgenesis (ORGS) United States $0.096B 0.00
VolitionRX (VNRX) Singapore $0.095B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.094B 0.00
ScPharmaceuticals (SCPH) United States $0.093B 0.00
Prima BioMed (IMMP) Australia $0.092B 0.00
Checkpoint Therapeutics (CKPT) United States $0.092B 0.00
Chiasma (CHMA) United States $0.090B 0.00
Cocrystal Pharma (COCP) United States $0.086B 0.00
OncoSec Medical (ONCS) United States $0.086B 0.00
Ophthotech (OPHT) United States $0.084B 0.55
Protalix BioTherapeutics (PLX) Israel $0.084B 0.00
Vaccinex (VCNX) United States $0.080B 0.00
NewLink Genetics (NLNK) United States $0.080B 0.00
Aptose Biosciences (APTO) Canada $0.079B 0.00
Sophiris Bio (SPHS) United States $0.077B 0.00
Alcobra (ARCT) United States $0.074B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.073B 0.00
Evogene (EVGN) Israel $0.070B 0.00
Curis (CRIS) United States $0.069B 0.00
BIONANO GENOMIC (BNGO) United States $0.069B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.069B 0.00
Alimera Sciences (ALIM) United States $0.068B 0.00
Celldex Therapeutics (CLDX) United States $0.068B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.066B 0.00
Oncobiologics (ONS) United States $0.066B 0.00
Trevena (TRVN) United States $0.066B 0.00
Entera Bio (ENTX) Israel $0.065B 0.00
Bellerophon Therapeutics (BLPH) United States $0.058B 0.00
Oncolytics Biotech (ONCY) Canada $0.056B 0.00
Fortress Biotech (FBIO) United States $0.055B 0.00
VistaGen Therapeutics (VTGN) United States $0.054B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Asterias Biotherapeutics (AST) United States $0.050B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.049B 0.00
Zosano Pharma (ZSAN) United States $0.048B 0.00
TRACON Pharmaceuticals (TCON) United States $0.047B 0.00
Celsion (CLSN) United States $0.047B 0.00
VIVUS (VVUS) United States $0.046B 0.00
Caladrius Biosciences (CLBS) United States $0.045B 0.00
AZURRX BIOPHARM (AZRX) United States $0.045B 0.00
GTx (GTXI) United States $0.045B 0.00
AquaBounty Technologies (AQB) United States $0.043B 0.00
Eyenovia (EYEN) United States $0.038B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.037B 0.00
BioPharmX (BPMX) United States $0.036B 0.00
Advaxis (ADXS) United States $0.036B 0.00
Proteon Therapeutics (PRTO) United States $0.035B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.035B 0.00
Galena Biopharma (SLS) United States $0.035B 0.00
Aileron Therapeutics (ALRN) United States $0.035B 0.00
Moleculin Biotech (MBRX) United States $0.032B 0.00
CytRx (CYTR) United States $0.029B 0.00
Cellect Biotechnology (APOP) Israel $0.028B 0.00
Vical (VICL) United States $0.027B 0.00
OvaScience (OVAS) United States $0.027B 0.00
Benitec Biopharma (BNTC) Australia $0.027B 0.00
GENPREX INC (GNPX) United States $0.027B 0.00
Histogenics (HSGX) United States $0.026B 0.00
Edge Therapeutics (EDGE) United States $0.025B 0.00
AEterna Zentaris (AEZS) United States $0.023B 46.33
Gemphire Therapeutics (GEMP) United States $0.022B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.022B 0.00
Arsanis (ASNS) United States $0.021B 0.00
RestorGenex (DFFN) United States $0.021B 0.00
TrovaGene (TROV) United States $0.021B 0.00
ATyr Pharma (LIFE) United States $0.020B 0.00
Soligenix (SNGX) United States $0.020B 0.00
Novelion Therapeutics (NVLN) Canada $0.019B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Prana Biotechnology (PRAN) Australia $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
Therapix Biosciences (TRPX) Israel $0.017B 6.19
Pulmatrix (PULM) United States $0.017B 0.00
IBio (IBIO) United States $0.015B 0.00
Adial Pharmaceuticals (ADIL) United States $0.014B 0.00
Neuralstem (CUR) United States $0.014B 0.00
Novogen (KZIA) Australia $0.014B 0.00
Oragenics (OGEN) United States $0.014B 0.00
Vital Therapies (VTL) United States $0.013B 0.00
Flex Pharma (FLKS) United States $0.011B 0.00
Cerulean Pharma (DARE) United States $0.011B 0.00
Alliqua BioMedical (ALQA) United States $0.010B 0.00
Hemispherx BioPharma (HEB) United States $0.010B 0.00
ARCA Biopharma (ABIO) United States $0.009B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Synthetic Biologics (SYN) United States $0.006B 0.00
AmpliPhi Biosciences (APHB) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
Aytu Bioscience (AYTU) United States $0.002B 0.00
Bio-Rad Laboratories (BIO.B) United States $0.000B 0.00
Y-MABS THERAPTC (YMAB) United States $0.000B 0.00